The overall objective of the Flow Cytometry Core is to efficiently provide CFAR members withcomprehensive flow cytometry services, including equipment, expertise and training at a reasonable cost.Flow cytometry is a unique and powerful technology for determining the phenotype and function of cells andalso allows defined populations of cells to be isolated by cell sorting. In recent years the use of flowcytometric analysis in HIV research has become even more prominent as new approaches for dissecting theinteractions between HIV and cells of the immune system have been developed. The CFAR Flow CytometryCore began operation in 1990 and continues to provide flow cytometry services to the AIDS researchers inthe UAB community. During the last budget period 82 individual investigators used the flow cytometry core,including 28 CFAR members for AIDS-related projects. The instrumentation in the core has also recentlybeen upgraded and now enables investigators to analyze six different parameters using three laser beamswith possible emissions at 360 nm, 407 nm, 488nm, 528 nm, 568 nm, or 633nm. In addition the CFAR FlowCytometry Core now also has available a FACScan instrument for five parameter, three color analysis.
The specific aims of the flow cytometry core are:1. Service. To provide AIDS Center members with cell sorting and analytical flow cytometry services,which are capable of handling potentially infectious materials.2. Education and Training. To provide AIDS Center members with up to date information regarding theuse of flow cytometry in AIDS research.3. Development. A major goal of the flow cytometry core is to address users' needs by ensuring that AIDSCenter members can take advantage of current technological advances and employ state of the arttechniques in their research activities.Overall the CFAR Flow Cytometry Core provides key resources, expertise and support to AIDSinvestigators at UAB and acts as a focal point for numerous scientific interactions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI027767-20S1
Application #
7697011
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Project Start
2008-09-16
Project End
2009-02-28
Budget Start
2008-09-16
Budget End
2009-02-28
Support Year
20
Fiscal Year
2008
Total Cost
$71,407
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Merlin, Jessica S; Long, Dustin; Becker, William C et al. (2018) Brief Report: The Association of Chronic Pain and Long-Term Opioid Therapy With HIV Treatment Outcomes. J Acquir Immune Defic Syndr 79:77-82
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Stafman, Laura L; Mruthyunjayappa, Smitha; Waters, Alicia M et al. (2018) Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma. Oncotarget 9:22665-22679
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618
Nag, Mukta; De Paris, Kristina; E Fogle, Jonathan (2018) Epigenetic Modulation of CD8? T Cell Function in Lentivirus Infections: A Review. Viruses 10:
Barr, Fiona D; Ochsenbauer, Christina; Wira, Charles R et al. (2018) Neutrophil extracellular traps prevent HIV infection in the female genital tract. Mucosal Immunol 11:1420-1428
Holdbrooks, Andrew T; Britain, Colleen M; Bellis, Susan L (2018) ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor. J Biol Chem 293:1610-1622
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Dixit, Saurabh; Sahu, Rajnish; Verma, Richa et al. (2018) Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4+ T cells. Biomaterials 159:130-145
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372

Showing the most recent 10 out of 955 publications